Population pharmacokinetics of subcutaneous infliximab CT-P13 in Crohn's disease and ulcerative colitis. Hanzel J, Bukkems LH, Gecse KB, D'Haens GR, et al. Aliment Pharmacol Ther 2021 Sep 24. doi: 10.1111/apt.16609.

Read + Share

Amedeo Smart

Independent Medical Education

Hanzel J, Bukkems LH, Gecse KB, D'Haens GR, et al. Population pharmacokinetics of subcutaneous infliximab CT-P13 in Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2021 Sep 24. doi: 10.1111/apt.16609.
PMID: 34559426